Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
June 02, 2021 08:03 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements,...
Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc.
May 18, 2021 09:25 ET
|
Guardion Health Sciences, Inc.
Acquisition to Transform and Strengthen Guardion’s Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the...
Guardion Health Sciences Announces Financial Results for the Three Months Ended March 31, 2021
May 17, 2021 16:05 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product
May 03, 2021 08:10 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Announces Financial Results for the Three Months and Year Ended December 31, 2020
March 26, 2021 08:00 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, March 26, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops science-based,...
Guardion Health Sciences Regains Compliance with Nasdaq Minimum Bid Price Rule
March 16, 2021 08:00 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 11, 2021 08:00 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically...
Guardion Health Sciences Announces 1-for-6 Reverse Stock Split Effective Pre-Market Opening on Monday, March 1, 2021
February 26, 2021 08:00 ET
|
Guardion Health Sciences, Inc.
Recent at-the-market financings and warrant exercises have netted a combined $37.2 million in 2021, providing an effective cash runway for program execution and acquisition strategy implementation ...
Malaysia’s Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences
January 28, 2021 16:15 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule
January 27, 2021 08:30 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...